Chew DP - Search Results

1

Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention.

Chan AW, Quinn MJ, Bhatt DL, Chew DP, Moliterno DJ, Topol EJ, Ellis SG. Chan AW, et al. Among authors: chew dp. J Am Coll Cardiol. 2002 Aug 21;40(4):669-75. doi: 10.1016/s0735-1097(02)02013-2. J Am Coll Cardiol. 2002. PMID: 12204496 Free article.

2

A critical appraisal of platelet glycoprotein IIb/IIIa inhibition.

Chew DP, Moliterno DJ. Chew DP, et al. J Am Coll Cardiol. 2000 Dec;36(7):2028-35. doi: 10.1016/s0735-1097(00)00979-7. J Am Coll Cardiol. 2000. PMID: 11127436 Free article. Review.

3

Oral glycoprotein IIb/IIIa antagonists in coronary artery disease.

Chew DP, Bhatt DL. Chew DP, et al. Curr Cardiol Rep. 2001 Jan;3(1):63-71. doi: 10.1007/s11886-001-0012-2. Curr Cardiol Rep. 2001. PMID: 11139801 Review.

4

Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery.

Bhatt DL, Chew DP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ. Bhatt DL, et al. Among authors: chew dp. Circulation. 2001 Jan 23;103(3):363-8. doi: 10.1161/01.cir.103.3.363. Circulation. 2001. PMID: 11157686 Clinical Trial.

5

Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials.

Chew DP, Bhatt DL, Lincoff AM, Moliterno DJ, Brener SJ, Wolski KE, Topol EJ. Chew DP, et al. Circulation. 2001 Feb 20;103(7):961-6. doi: 10.1161/01.cir.103.7.961. Circulation. 2001. PMID: 11181470

6

Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials.

Chew DP, Bhatt DL, Sapp S, Topol EJ. Chew DP, et al. Circulation. 2001 Jan 16;103(2):201-6. doi: 10.1161/01.cir.103.2.201. Circulation. 2001. PMID: 11208677

7

Update on Pharmacology for Restenosis.

Chan AW, Chew DP, Lincoff AM. Chan AW, et al. Among authors: chew dp. Curr Interv Cardiol Rep. 2001 May;3(2):149-155. Curr Interv Cardiol Rep. 2001. PMID: 11322918

8

Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding risk.

Mukherjee D, Chew DP, Robbins M, Yadav JS, Raymond RE, Moliterno DJ. Mukherjee D, et al. Among authors: chew dp. J Thromb Thrombolysis. 2001 Apr;11(2):151-4. doi: 10.1023/a:1011228817265. J Thromb Thrombolysis. 2001. PMID: 11406730 Free article.

9

Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention.

Chew DP, Bhatt DL, Robbins MA, Penn MS, Schneider JP, Lauer MS, Topol EJ, Ellis SG. Chew DP, et al. Circulation. 2001 Aug 28;104(9):992-7. doi: 10.1161/hc3401.095074. Circulation. 2001. PMID: 11524391

10

Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein.

Chew DP, Bhatt DL, Robbins MA, Mukherjee D, Roffi M, Schneider JP, Topol EJ, Ellis SG. Chew DP, et al. Am J Cardiol. 2001 Sep 15;88(6):672-4. doi: 10.1016/s0002-9149(01)01813-6. Am J Cardiol. 2001. PMID: 11564394 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters